Bristol-Myers Decries Blue Cross Unit's Last-Minute Dropout
By Bryan Koenig · December 5, 2023, 5:06 PM EST
Celgene and parent Bristol-Myers Squibb expressed frustration Tuesday about the timing of a Blue Cross unit's decision to bow out as a plaintiff in New Jersey federal court antitrust litigation accusing...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login